Nektar Therapeutics | NKTR - Créances Commerciales





Créances Commerciales Changement Date
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
ALKERMES USD 456.48M 48.85M 2026-06
Alterity Therapeutics Limited AUD 4.57M 1.42M 2025-12
Amgen USD 10.23B 1.09B 2026-06
Baxter International USD 1.86B 158M 2026-06
BioCryst Pharmaceuticals USD 110.76M 3.94M 2026-06
Biogen USD 1.79B 76.6M 2026-03
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Cara Therapeutics USD 2.24M 2.26M 2025-03
Cipla INR 62.19B 12.42B 2026-03
Dr.Reddys Laboratories INR 124.42B 19.68B 2026-06
Eisai JPY 253.13B 26.12B 2026-06
Eli Lilly USD 23.48B 2.3B 2026-06
Exelixis USD 322.21M 6.73M 2026-06
Gilead Sciences USD 5.06B 314M 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
Grifols EUR 1B 285.88M 2025-12
Halozyme Therapeutics USD 453.33M 4.66M 2026-06
Incyte USD 1.13B 73.7M 2026-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
MacroGenics USD 10.42M 2.95M 2026-03
Merck USD 12.21B 435M 2026-03
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Neurocrine Biosciences USD 887M 118.9M 2026-06
Novartis USD 9.85B 252M 2026-06
Pfizer USD 16.19B 19M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
Takeda JPY 956.14B 79.79B 2026-06
Teva Pharmaceutical Industries USD 3.49B 100M 2026-06
Xencor USD 42.23M 30.23M 2026-06